Loading
Longwood Fund
Longwood Fund is a Boston venture firm that founds and funds early biotech companies, several of them in cancer.
Overview
Longwood Fund is a Boston-based healthcare venture firm founded in 2010 that creates and invests in early-stage biotechnology companies, frequently as a founding investor working with academic scientists. Oncology has been a recurring area, including immuno-oncology and precision medicine companies. Portfolio links in OnCo are derived from the startup records that name it.
Portfolio
2Portfolio (2)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Neomorph San Diego, CA, US | Startup | biotech | Renal cell carcinoma | Series B 2026, $100M |
| Photys Therapeutics Boston, MA, US | Startup | biotech | Series A 2022, $75M |
Connected
2Similar pages
- CompanyDeerfield Management
Shares Neomorph and the tag vc.
- CompanyOmega Funds
Shares Photys Therapeutics and the tag vc.
- CompanyMPM BioImpact
Shares Photys Therapeutics and the tag vc.
companies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
longwoodfund.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/